NFKB1 and nervous system disorder: Furthermore, our data indicated that MSC-Exo could restore A1 astrocyte activation via regulation of Nrf2-NF-κB signaling pathway, suggesting that MSC-Exo can be a potential nanotherapeutic agent for the treatment of neurological diseases whose pathological basis entails hippocampal astrocytic alterations.